Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

A breath of fresh air.

Rowe SM, Clancy JP, Sorscher EJ.

Sci Am. 2011 Aug;305(2):68-73. No abstract available.

PMID:
21827128
2.

Pharmacologic approaches to correcting the basic defect in cystic fibrosis.

Lukacs GL, Durie PR.

N Engl J Med. 2003 Oct 9;349(15):1401-4. No abstract available.

PMID:
14534332
3.

Cystic fibrosis.

Rowe SM, Miller S, Sorscher EJ.

N Engl J Med. 2005 May 12;352(19):1992-2001. No abstract available.

PMID:
15888700
4.

Emerging drug treatments for cystic fibrosis.

Zeitlin PL.

Expert Opin Emerg Drugs. 2007 May;12(2):329-36. Review.

PMID:
17604505
5.
6.

Can curcumin cure cystic fibrosis?

Zeitlin P.

N Engl J Med. 2004 Aug 5;351(6):606-8. No abstract available.

PMID:
15295056
7.

Drug bests cystic-fibrosis mutation.

Ledford H.

Nature. 2012 Feb 7;482(7384):145. doi: 10.1038/482145a. No abstract available.

PMID:
22318583
8.

[From gene to disease; from defective chloride ion transport to cystic fibrosis].

Scheffer H, van den Ouweland AM, Veeze HJ.

Ned Tijdschr Geneeskd. 2001 Apr 7;145(14):686-7. Review. Dutch.

PMID:
11530706
9.

Emerging drug treatments for cystic fibrosis.

Zeitlin PL.

Expert Opin Emerg Drugs. 2003 Nov;8(2):523-35. Review.

PMID:
14662004
10.

Emerging therapies for cystic fibrosis lung disease.

Grasemann H, Ratjen F.

Expert Opin Emerg Drugs. 2010 Dec;15(4):653-9. doi: 10.1517/14728214.2010.517746. Epub 2010 Sep 3. Review.

PMID:
20812885
11.

Cystic fibrosis transmembrane conductance regulator. Structure and function of an epithelial chloride channel.

Akabas MH.

J Biol Chem. 2000 Feb 11;275(6):3729-32. Review. No abstract available.

13.

[Correction of CFTR anomalies: pharmacological approach].

Chinet T.

Arch Pediatr. 2000 May;7 Suppl 2:352s-354s. French. No abstract available.

PMID:
10904771
14.

Cystic fibrosis: the 'bicarbonate before chloride' hypothesis.

Wine JJ.

Curr Biol. 2001 Jun 26;11(12):R463-6.

15.

How do cystic fibrosis transmembrane conductance regulator mutations produce lung disease?

Pilewski JM, Frizzell RA.

Curr Opin Pulm Med. 1995 Nov;1(6):435-43. Review.

PMID:
9363079
16.

Chloride channels and cystic fibrosis of the pancreas.

Gray MA, Winpenny JP, Verdon B, McAlroy H, Argent BE.

Biosci Rep. 1995 Dec;15(6):531-41. Review.

PMID:
9156582
17.

Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator I1234V mutation.

Abdul-Wahab A, Janahi IA, Abdel-Rahman MO.

Saudi Med J. 2009 Aug;30(8):1101-2. No abstract available.

PMID:
19668897
18.

CFTR chloride channel drug discovery--inhibitors as antidiarrheals and activators for therapy of cystic fibrosis.

Verkman AS, Lukacs GL, Galietta LJ.

Curr Pharm Des. 2006;12(18):2235-47. Review.

PMID:
16787252
19.

Cystic fibrosis.

Welsh MJ, Smith AE.

Sci Am. 1995 Dec;273(6):52-9. No abstract available.

PMID:
8525348
20.

Structure-function analysis of a double-mutant cystic fibrosis transmembrane conductance regulator protein occurring in disorders related to cystic fibrosis.

Fanen P, Clain J, Labarthe R, Hulin P, Girodon E, Pagesy P, Goossens M, Edelman A.

FEBS Lett. 1999 Jun 11;452(3):371-4.

Items per page

Supplemental Content

Write to the Help Desk